Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
39.17
-0.02 (-0.05%)
Nov 20, 2024, 4:00 PM EST - Market closed
Surmodics Employees
Surmodics had 376 employees as of September 30, 2023. The number of employees decreased by 71 or -15.88% compared to the previous year.
Employees
376
Change (1Y)
-71
Growth (1Y)
-15.88%
Revenue / Employee
$335,314
Profits / Employee
-$30,697
Market Cap
561.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Organogenesis Holdings | 862 |
Standard BioTools | 539 |
Axogen | 428 |
IGM Biosciences | 224 |
Simulations Plus | 197 |
Humacyte | 185 |
Alumis | 109 |
Astria Therapeutics | 59 |
SRDX News
- 15 days ago - Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - Business Wire
- 21 days ago - Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - Business Wire
- 7 weeks ago - Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter - Business Wire
- 4 months ago - Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results - Business Wire
- 4 months ago - SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Business Wire
- 5 months ago - Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. - Business Wire
- 6 months ago - SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Accesswire
- 6 months ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. - PRNewsWire